<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03253315</url>
  </required_header>
  <id_info>
    <org_study_id>ayafadl24791</org_study_id>
    <nct_id>NCT03253315</nct_id>
  </id_info>
  <brief_title>Management of Pericarditis in Children.</brief_title>
  <official_title>Clinical Audit of the Management of Pericarditis in Children.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The pericardium is a double-walled sac containing the heart and the roots of the great&#xD;
      vessels. The pericardial sac has two layers, a serous visceral l layer (also known as&#xD;
      epicardium when it comes into contact with the myocardium) and a fibrous parietal layer. It&#xD;
      encloses the pericardial cavity, which contains pericardial fluid. The pericardium fixes the&#xD;
      heart to the mediastinum, gives protection against infection and provides lubrication for the&#xD;
      heart. Pericardial diseases may be either isolated disease or part of a systemic disease&#xD;
      Diseases of the pericardium present clinically in one of several ways&#xD;
&#xD;
        -  Acute and recurrent pericarditis&#xD;
&#xD;
        -  Pericardial effusion without major hemodynamic compromise&#xD;
&#xD;
        -  Cardiac tamponade with cardiac compromise&#xD;
&#xD;
        -  Constrictive pericarditis&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Pericarditis usually present with chest pain and dyspnea. Effusion can present with no&#xD;
           symptoms, dull ache in left chest and abdominal pain Cardiac tamponade is recognized by&#xD;
           the excessive fall of systolic blood pressure&#xD;
&#xD;
        -  Diagnostic workup A) Chest X-ray:_ chest X-ray can detect varying degree of&#xD;
           cardiomegaly. B) Echocardiography: It is the first-line imaging test. clinically,&#xD;
           two-dimensional echocardiography with Doppler provides the most cost-effective way of&#xD;
           diagnosing C) Electrocardiograph D) cardiac computerized tomography :- Also may be&#xD;
           helpful 4)Therapy of pericarditis in pediatrics the medical lines of treatment of&#xD;
           pericarditis are:_ A)Aspirin and non-steroidal anti-inflammatory:_ are the mainstay of&#xD;
           the therapy of inflammatory pericardial diseases B)Steroids: a minority of patients will&#xD;
           require treatment with systemic steroid therapy as&#xD;
&#xD;
             -  Patients with symptoms refractory to standard therapy&#xD;
&#xD;
                  -  Acute pericarditis due to connective tissue disease ●Uremic pericarditis&#xD;
                     C)Immunosuppressant and biological drugs (more commonly used in recurrent&#xD;
                     pericarditis) .Interventional therapeutic techniques-_&#xD;
&#xD;
      Most patients with acute pericarditis can be managed effectively with medical therapy alone.&#xD;
      However, patients may require invasive therapies for:&#xD;
&#xD;
        -  A moderate to large pericardial effusion, particularly if hemodynamically significant.&#xD;
&#xD;
        -  Frequent, highly symptomatic recurrences of acute pericarditis with pericardial effusion&#xD;
           ●Evidence of constrictive pericarditis (a late occurrence when present) A)Pericardial&#xD;
           drainage :Prolonged catheter drainage of a pericardial effusion is an effective means of&#xD;
           preventing fluid reaccumulation.&#xD;
&#xD;
      B)Pericardiotomy, pericardial window and pericardiectomy: pericardiectomy may be considered&#xD;
      for frequent and highly symptomatic recurrences of pericarditis tamponade .. C)Surgical&#xD;
      decompression of the pericardium :_can be achieved either by conventional heart surgery or&#xD;
      video-assisted thoracoscopy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">September 2017</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>15 Days</target_duration>
  <primary_outcome>
    <measure>Echocardiographic signs</measure>
    <time_frame>one month</time_frame>
    <description>normal cardiac size by echocardiography (measurable by echocardiographic probe)&#xD;
normal thickening of pericardium by echocardiography .(measurable by echocardiographic probe)</description>
  </primary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Pericarditis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients who above one year of age up to 18 years diagnosed with pericarditis and/or&#xD;
        pericardial effusions are candidates for the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children with pericarditis and/or pericardial effusion above one year of age detected&#xD;
             clinically and by echocardiography&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  children below one year of age. - children with malignant effusion.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Months</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Assiut University</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>nagwa ali, MD</last_name>
      <phone>01096260950</phone>
      <email>namma65@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <study_first_submitted>August 7, 2017</study_first_submitted>
  <study_first_submitted_qc>August 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2017</study_first_posted>
  <last_update_submitted>August 15, 2017</last_update_submitted>
  <last_update_submitted_qc>August 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>aya gomaa mohamed</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pericarditis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

